For Reuters Pharma Europe 2025, pharmaphorum is providing coverage courtesy NAVLIN Daily, a pricing and market access insights report from EVERSANA (pharmaphorum's parent company). You can see the ...
NEW YORK — “Face Value: Celebrity Press Photography” is an odd show, but the oddness helps make it a revealing view on one of the odder aspects of this culture — no, not the press (odd as that may be) ...
Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, economics, and public policy. Peter began covering markets at Multex (Reuters) and has ...
Cinnamon is a spice rich in antioxidants, such as cinnamaldehyde. Some studies suggest that cinnamon may provide certain health benefits, including blood sugar management, protection against heart ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Avocados are a source of many key nutrients, including healthy fats and fiber. They also contain anti-inflammatory and antioxidant compounds that may help reduce the risk of heart disease. As you can ...
Life on Earth may have origins from far, far away. Scientists have found a full set of life-building molecules in a nearly pristine asteroid sample, and the discovery suggests that the necessary ...
Urticaria, also known as hives, is an outbreak of pale red bumps or welts on the skin that appear suddenly. The swelling that often comes with hives is called angioedema. Allergic reactions, chemicals ...
Selene Yeager is a health and fitness writer with over 25 years of experience. Her work has appeared in Shape, O, the Oprah Magazine, Men’s Health, Women's Health, Marie Claire, Good Housekeeping, ...
This fund is benchmarked to the Russell 1000 Growth index, but manager Giri Devulapally’s objective is to beat index returns by zeroing in on large growth companies with industry leadership and price ...
This fund is benchmarked to the Russell 1000 Growth index, but manager Giri Devulapally’s objective is to beat index returns by zeroing in on large growth companies with industry leadership and price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results